HIF1A and neoplasm: Among these derivatives, N-butyryl-5-methoxytryptamine (NB-5-MT) (Figure 7) exhibited the highest anti-tumor potency, resulting in reduced expression of HIF-1α, decreased transcription of HIF-1α gene targets, and inhibition of angiogenesis both in vitro and in vivo.